You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY22 is not expected to be complete until September, 2023.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. Tactical Sensor Open Standards Integration

    SBC: Botts Innovative Research Inc            Topic: SOCOM202001

    Botts Innovative Research, Inc (Botts, Inc.) proposes to conduct a feasibility study to assess the art of the possible as it relates to the use of the open source, open standards based OpenSensorHub (OSH) (www.OpenSensorHub.org) for the integration between the sensors and robots of Hyper Enabled Operators (HEO), their units, and their mission command, to provide battlespace awareness at the tactic ...

    SBIR Phase I 2020 Department of DefenseSpecial Operations Command
  2. Optimized Platforms for Proper Glycosylation and Sialylation of Recombinant Human Butyrylcholinesterase (rBChE)

    SBC: ECHELON BIOSCIENCES, INC.            Topic: CBD192007

    Organophosphorus (OP) toxins and chemical warfare agents (CWA) are active nerve agents posing significant hazard for both soldiers and civilians. Butyrylcholinesterase (BChE) is a safe and effective bioscavenger that detoxifies OP and CWAs when injected either prophylactically or post-exposure; but a major technical problem has been producing a recombinant form of BChE with acceptable properties f ...

    SBIR Phase I 2020 Department of DefenseOffice for Chemical and Biological Defense
  3. Succor Combat Foam for Treatment of Dermal Injuries Caused by Sulfur Mustard

    SBC: Critical Innovations LLC            Topic: CBD212005

    The Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical) seeks to develop dermal dressing technologies that provide multiple advantages over current wound dressings for treating dermal injuries caused by sulfur mustard. Critical Innovations, Battelle's Biomedical Research Center, and NDA Partners, with consultants Captain David Tanen, MD, FAAEM, FACM ...

    SBIR Phase I 2022 Department of DefenseOffice for Chemical and Biological Defense
  4. Optimized Platforms for Proper Glycosylation and Sialylation of Recombinant Human Butyrylcholinesterase (rBChE)

    SBC: Technology Holding, LLC            Topic: CBD192007

    The threat of organophosphate (OP) chemical warfare agents (CWA) to United States military personnel is a persistent problem due to the relative ease of manufacturing chemical threats compared to nuclear and biological agents. Human butyrylcholinesterase (BChE) has been identified as a probable bio-scavenger of OP CWAs that could be used to protect individuals that could be exposed to OP CWAs. The ...

    SBIR Phase I 2020 Department of DefenseOffice for Chemical and Biological Defense
  5. CBRNE Augmented Reality Display and Device Integration Network

    SBC: INTELLISENSE SYSTEMS INC            Topic: CBD212002

    To address the CBD’s need for an augmented reality (AR) display that shows chemical, biological, radiological, nuclear (CBRN), and electro-optical/infrared (CBRNE) threats, Intellisense Systems, Inc. (Intellisense) proposes to develop a new CBRNE Augmented Reality Display and Device Integration Network (CARDDIN), based on a modular network that incorporates CBRNE and geolocation information from ...

    SBIR Phase I 2022 Department of DefenseOffice for Chemical and Biological Defense
  6. Aerosol Ionization Mass Spectrometer (AIMS)

    SBC: Hedgefog Research Inc.            Topic: CBD212003

    There is an urgent need to rapidly test warfighters and their surrounding environment for disease-causing pathogens such as SARS-CoV-2. Existing methods for identifying pathogens in people usually require significant time and sample preparation. In addition, detecting pathogens such as SARS-CoV-2 in the air presents an even greater challenge. To meet the DoD need for field portable bioaerosol iden ...

    SBIR Phase I 2022 Department of DefenseOffice for Chemical and Biological Defense
  7. Non-Invasive Monitoring of Changes in Intracranial Pressure Due to Infections in the Central Nervous System

    SBC: Fenix Research Corporation            Topic: CBD192005

    Infections of the central nervous system (CNS) are associated with brain swelling and increased cerebral blood volume, as well as focal cerebral perfusion deficits, variable levels of cerebral blood flow and cerebral vasculitis. The net result is increased intracranial pressure (ICP) along with significant risk of brain tissue herniation and ischemic syndromes. ICP monitoring is critical in the ma ...

    SBIR Phase I 2020 Department of DefenseOffice for Chemical and Biological Defense
  8. Chemical-Imaging Registration and Multi-modal Analysis

    SBC: INTELLISENSE SYSTEMS INC            Topic: CBD212001

    To address the Chemical and Biological Defense (CBD) agency’s need for a new deep learning (DL)-based threat detection solution that fuses imaging sensors and chemical/biological sensors to detect and locate concealed chemical threats, Intellisense Systems, Inc. (Intellisense) proposes development of a new Chemical-Imaging Registration and Multimodal Analysis (CIGMA) solution. CIGMA will compris ...

    SBIR Phase I 2022 Department of DefenseOffice for Chemical and Biological Defense
  9. Multi Injection Vial Anti-contamination cap (MIVA-Cap)

    SBC: Chromologic LLC            Topic: CBD212004

    To meet CBD’s need for a multi-dose formulation of scopolamine hydrobromide trihydrite ChromoLogic proposes to develop a vial add-on containing a self-decontamination cap with a self-healing material to eliminate evaporation and contamination risks through needle punctures in the septum. CL will also perform forced degradation and stability tests with a panel of preservatives to select optimal p ...

    SBIR Phase I 2022 Department of DefenseOffice for Chemical and Biological Defense
  10. Portable Cold Plasma System for Biowarfare Agent Decontamination

    SBC: CFD RESEARCH CORP            Topic: CBD203003

    Biowarfare agents pose a significant threat to military personnel and operations. Effective decontamination strategies that eliminate the biowarfare agents prior to human exposure can help mitigate risks associated with exposure. Traditional decontamination techniques rely on “wet” solutions such as chemicals including bleach. However, these decontaminants are unsuitable for sensitive equipmen ...

    SBIR Phase I 2021 Department of DefenseOffice for Chemical and Biological Defense
US Flag An Official Website of the United States Government